Your browser doesn't support javascript.
loading
Initial experience with pulsed field ablation for atrial fibrillation.
Magni, Federico T; Mulder, Bart A; Groenveld, Hessel F; Wiesfeld, Ans C P; Tieleman, Robert G; Cox, Moniek G; Van Gelder, Isabelle C; Smilde, Tom; Tan, Eng S; Rienstra, Michiel; Blaauw, Yuri.
Afiliación
  • Magni FT; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Mulder BA; Department of Cardio-thoracic Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Groenveld HF; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Wiesfeld ACP; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Tieleman RG; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Cox MG; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Van Gelder IC; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Smilde T; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Tan ES; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Rienstra M; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Blaauw Y; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Front Cardiovasc Med ; 9: 959186, 2022.
Article en En | MEDLINE | ID: mdl-36426226
ABSTRACT

Introduction:

Pulsed field ablation (PFA) was recently introduced for the treatment of symptomatic atrial fibrillation (AF) with the claim of selectively ablating the myocardium while sparing surrounding tissues. We present our initial experience with a PFA catheter for pulmonary vein isolation (PVI) and describe procedural findings and peri-procedural safety of the first 100 patients. Materials and

methods:

We investigated 100 patients treated for symptomatic AF using the FARAWAVE PFA catheter (Farapulse, Menlo Park, CA, USA) between July 2021 and March 2022. Procedure workflow and electrophysiological findings at the time of ablation, peri-procedural complications, and operator learning curves are described.

Results:

The mean age of patients was 62.9 ± 9.4 years, 62% were male subjects and 80% had paroxysmal AF. The median CHA2DS2-VASc score was 1.5 (IQR 1.0-2.0) and the mean left atrial volume index was 35.7 ± 9.6 ml/m2. In 88 (88%) patients, PVI alone was performed and in 12 (12%) patients additional ablation of the posterior wall was performed. 3D-electroanatomic mapping was performed in 18 (18%) patients. Procedures without mapping lasted for 52.3 ± 16.6 min. The mean number of applications per pulmonary vein (PV) was 8.1 ± 0.6. In all patients (100%), all PVs were confirmed to be isolated. The learning curves of the two operators who performed > 20 procedures showed a negligible variation of performance over time and practice did not significantly predict procedure time [Operator 1 (senior) R 2 = 0.034, p = 0.35; Operator 2 (junior) R 2 = 0.004, p = 0.73]. There was no difference between the procedure times between senior and junior operators (Operator 1 46.9 ± 9.7 min vs. Operator 2 45.9 ± 9.9 min; p = 0.73). The only complications observed were two cases of bleeding at the site of percutaneous access.

Conclusion:

Our initial experience shows that use of the PFA catheter for pulmonary vein isolation (PVI) is safe, fast, and easy to learn.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
...